Literature DB >> 12888145

Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia.

Juan Quiles1, Debashis Roy, David Gaze, Iris Paula Garrido, Pablo Avanzas, Manas Sinha, Juan Carlos Kaski.   

Abstract

The results in this study confirm and expand previous reports that ischemia-modified albumin (IMA) is an early marker of ischemia in the setting of percutaneous coronary intervention (PCI). We observed that IMA levels are related to the number of inflations, inflation pressure, and duration of inflations. It is therefore likely that IMA reflects the magnitude and duration of ischemia induced during PCI.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12888145     DOI： 10.1016/s0002-9149(03)00638-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  9 in total

1.  When prognosis precedes diagnosis: putting the cart before the horse.

Authors:  Marc S Sabatine
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

2.  Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome.

Authors:  Andrew Worster; P J Devereaux; Diane Heels-Ansdell; Gordon H Guyatt; John Opie; Farouk Mookadam; Stephen A Hill
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

3.  Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction.

Authors:  James Chek; Jaroslav Dusek; Josef Stasek; Jan Vojacek; Josef Bis; Martina Ulrychova; Milos Tichy; Tomas Tomko; Josef Bukac
Journal:  Heart Vessels       Date:  2011-01-26       Impact factor: 2.037

4.  Ischemia-modified albumin in acute aortic dissection.

Authors:  Eftihia Sbarouni; Panagiota Georgiadou; Aikaterini Marathias; Demosthenes Panagiotakos; Stefanos Geroulanos; Vassilis Voudris
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

5.  Proteomics and mass spectrometry: what have we learned about the heart?

Authors:  Shaan Chugh; Colin Suen; Anthony Gramolini
Journal:  Curr Cardiol Rev       Date:  2010-05

6.  Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain.

Authors:  Luciano Consuegra-Sanchez; Alberto Bouzas-Mosquera; Manas K Sinha; Paul O Collinson; David C Gaze; Juan Carlos Kaski
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

7.  Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.

Authors:  Muhip Kanko; Sadan Yavuz; Can Duman; Tulay Hosten; Emin Oner; Turan Berki
Journal:  J Cardiothorac Surg       Date:  2012-01-05       Impact factor: 1.637

8.  Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests.

Authors:  June Hong Kim; Jae Hoon Choi; Hyun-Kook Lee; Woo Hyung Bae; Kook-Jin Chun; Yun Seong Kim; Sang Kwon Lee; Hyung Hoi Kim; Taek Jong Hong; Yong Woo Shin
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 3.165

9.  Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.

Authors:  Yüksel Çavuşoğlu; Şule Korkmaz; Selda Demirtaş; Erkan Gencer; Hatice Şaşmaz; Fezan Mutlu; Hakan Güneş; Uğur Kadir Mert; Sedat Özdemir; Süleyman Kalaycı; Mehmet Birhan Yılmaz
Journal:  Anatol J Cardiol       Date:  2015-08       Impact factor: 1.596
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.